000 | 01121 a2200325 4500 | ||
---|---|---|---|
005 | 20250515045516.0 | ||
264 | 0 | _c20070801 | |
008 | 200708s 0 0 eng d | ||
022 | _a0172-8172 | ||
024 | 7 |
_a10.1007/s00296-006-0254-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPeiró, A M | |
245 | 0 | 0 |
_aCitalopram-induced Raynaud's phenomenon. _h[electronic resource] |
260 |
_bRheumatology international _cApr 2007 |
||
300 |
_a599-601 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
650 | 0 | 4 |
_aCitalopram _xadverse effects |
650 | 0 | 4 |
_aDepressive Disorder _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeuralgia _xdrug therapy |
650 | 0 | 4 |
_aRaynaud Disease _xchemically induced |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
700 | 1 | _aMargarit, C | |
700 | 1 | _aTorra, M | |
773 | 0 |
_tRheumatology international _gvol. 27 _gno. 6 _gp. 599-601 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00296-006-0254-9 _zAvailable from publisher's website |
999 |
_c16675523 _d16675523 |